Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

External validation of the HALP score for predicting in-hospital and long-term outcomes in acute heart failure: a retrospective cohort study.

Created on 14 Nov 2026

Authors

Mehmet Zafer Aydın, Mustafa Gök, Mehmet Kamil Teber, Zülfiye Kuzu, Ziya Şimşek

Published in

Frontiers in cardiovascular medicine. Volume 13. Pages 1958343. Epub Oct 30, 2026.

Abstract

The hemoglobin-albumin-lymphocyte-platelet (HALP) score integrates nutritional, inflammatory, and hematologic status and has been proposed as a prognostic marker in acute heart failure (AHF), but external validation is limited.
We retrospectively analyzed 197 consecutive patients hospitalized with AHF at a tertiary center. HALP was calculated at admission, and the pre-specified outcomes were in-hospital mortality, prolonged hospital stay (>7 days), all-cause mortality over follow-up, and heart-failure rehospitalization. Discrimination was assessed by the area under the receiver-operating-characteristic curve (AUC) with DeLong 95% confidence intervals (CIs), and associations were tested with crude and age/sex-adjusted logistic regression (in-hospital outcomes) and Cox regression (mortality over follow-up), using both data-derived (Youden) and pre-specified HALP thresholds.
The cohort had a median age of 71 years (30.5% female) and a median follow-up of 15.5 months; in-hospital mortality was 12.7%, prolonged stay 19.4%, and all-cause mortality 31.0%. HALP did not discriminate any outcome (AUC 0.53 [95% CI 0.41-0.65] for in-hospital mortality, 0.47 [0.36-0.59] for prolonged stay, and 0.57 [0.48-0.66] for all-cause mortality; all CIs included 0.50). A Youden-optimized threshold appeared associated with mortality in logistic regression (adjusted odds ratio 2.02, 95% CI 1.02-4.00), but the signal vanished under pre-specified thresholds (median-split adjusted odds ratio 1.23, 0.67-2.28) and in time-to-event analysis (adjusted hazard ratio per 1-SD decrease 1.04, 0.78-1.38; Youden threshold 1.75, 0.97-3.16; log-rank across quartiles p = 0.15). In the same patients, the established EHMRG and MAGGIC scores discriminated mortality (AUC 0.71 and 0.65; CIs excluding 0.50), whereas HALP correlated only with severity markers (NYHA class rho = -0.31; NT-proBNP rho = -0.16; CRP rho = -0.17).
In this independent cohort, HALP reflected disease severity but did not predict outcomes once cutoff-optimization bias was removed, and should not be used as a stand-alone risk-stratification tool in AHF.

PMID:
43031635
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement